Format

Send to

Choose Destination
See comment in PubMed Commons below
Endocr Pract. 2014 Jan;20(1):70-4. doi: 10.4158/EP13165.RA.

Effect of the preoperative use of dopamine agonists in the postoperative course of prolactinomas: a systematic review.

Author information

1
Clinical Department of Neurosurgery, Clinical Hospital Center, Spinciceva 1, 21000 Split, Croatia.
2
Department of Neurology, Clinical Hospital Center, Spinciceva 1, 21000 Split, Croatia.

Abstract

OBJECTIVE:

Since the 1980s, it has been discussed whether the preoperative treatment of prolactinomas with dopamine agonists (DAs) is beneficial or detrimental regarding postoperative residue or recurrence. Many neurosurgeons have emphasized the difficulties caused by fibrosis during the ablation of such prolactinomas.

METHODS:

From February to December 2012, the authors searched electronic databases and book chapters published from 1991 to 2012; a total of 3,771 articles and 37 book chapters were searched. Ten articles that explicitly addressed this issue were identified.

RESULTS:

Five articles reported that preoperative treatment did not affect postoperative status. One article described a positive influence of preoperative treatment with DAs (P < .01), and 3 articles found a negative influence (P = .040, P = .02, no significance value reported). One article described histopathological evidence of tumor fibrosis that was found intraoperatively after preoperative DA treatment.

CONCLUSIONS:

This systematic review did not identify any strong evidence that preoperative treatment of prolactinomas with DAs is harmful or beneficial. Therefore, further studies are needed.

PMID:
24013992
DOI:
10.4158/EP13165.RA
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Allen Press, Inc.
    Loading ...
    Support Center